
    
      Five participants randomized to the docetaxel 100 mg/m^2 plus placebo group actually received
      docetaxel 100 mg/m^2 plus bevacizumab 7.5 mg/kg and are included in the docetaxel 100 mg/m^2
      plus bevacizumab 7.5 mg/kg group for the adverse event results. Sixteen participants
      randomized to the docetaxel 100 mg/m^2 plus placebo group actually received docetaxel 100
      mg/m^2 plus bevacizumab 15.0 mg/kg and are included in the docetaxel 100 mg/m^2 plus
      bevacizumab 15.0 mg/kg group for the adverse event results.
    
  